# Repair-Pathway Research Compounds

RECOVERY & REPAIR — RESEARCH COMPOUNDS

# Tissue repair is studied in phases, and different compounds map to different phases.

BPC-157 + TB-500, IGF-1 LR3 and KPV — angiogenesis and cell migration, growth-factor signalling, and inflammatory pathways.

[Bundle & Save 20% →](https://portaltowellness.net/shop/recovery-repair-bundle/)
[View Individual Compounds](https://portaltowellness.net/shop/recovery-repair-bundle/)

✓ Save 20% — $37.40 off when you buy these together

📦 Ships in 1–2 Business Days

📚 Published research linked per compound

Why This Stack

## What these compounds are studied for.

The repair literature describes overlapping phases: an inflammatory phase, a proliferative phase in which tissue rebuilds and vascularises, and a remodelling phase. Compounds are studied against one or more of those phases, in specific tissues, in specific models — most of it preclinical. BPC-157 is studied for angiogenesis and tendon, ligament and gut tissue in animal models. TB-500 is studied for actin polymerisation and repair-cell migration. IGF-1 LR3 is a modified analogue studied for extended growth-factor signalling. KPV is an alpha-MSH fragment studied for anti-inflammatory activity in gut and mucosal models. A marker moving in a model is not a tissue healing in a person, and none of these is approved to treat anything.

Compound Composition

## What’s in this stack.

COMPOUND 01

BPC-157 + TB-500 — 10mg/vial (5mg each)

Pre-mixed vial containing both peptides. BPC-157 is studied for angiogenesis and for tendon, ligament and gut tissue in animal models. TB-500 is studied for actin polymerisation and repair-cell migration. These are two separate research questions; supplying them in one vial is a packaging convenience and not a statement that they act together.

Retail: $69.00

$55.20 with bundle

[Add This Only](?add-to-cart=695)

COMPOUND 02

IGF-1 LR3 — 1mg/vial

Modified IGF-1 analogue with a 13-amino-acid N-terminal extension that reduces IGF-binding-protein affinity. Studied for extended growth-factor signalling in research models.

Retail: $62.00

$49.60 with bundle

[Add This Only](?add-to-cart=699)

COMPOUND 03

KPV — 10mg/vial

C-terminal tripeptide of alpha-MSH (Lys-Pro-Val). Studied for anti-inflammatory activity in gut and mucosal models, including effects on NF-κB signalling in intestinal epithelium.

Retail: $56.00

$44.80 with bundle

[Add This Only](?add-to-cart=114)

Mechanisms

## What the published work describes.

1

#### BPC-157 + TB-500 — Structural Repair & Cellular Mobilization

BPC-157 is a synthetic pentadecapeptide stable in gastric juice. It promotes angiogenesis through VEGF and nitric oxide pathway upregulation, and upregulates growth hormone receptor expression at injury sites — accelerating tendon-to-bone healing in research models. TB-500 promotes G-actin sequestration and F-actin polymerization, the cytoskeletal process that allows repair cells to migrate toward injury signals. The two peptides are supplied pre-mixed. PTW does not publish guidance on combining compounds.

2

#### IGF-1 LR3 — Growth Factor Amplification

The N-terminal extension reduces binding to IGF-binding proteins, extending half-life and prolonging downstream signalling. Research models report effects on satellite-cell activation and on IGF-1 receptor-mediated proliferation. Those are findings in models.

3

#### KPV — Systemic Anti-Inflammatory & Gut Barrier Repair

Lys-Pro-Val is the C-terminal tripeptide of alpha-MSH, retaining anti-inflammatory activity in a more stable form. In research models it downregulates NF-κB signalling in immune cells and intestinal epithelium, reduces inflammatory cytokine expression (TNF-α, IL-6, IL-1β), and is studied for intestinal epithelial barrier repair in IBD models. That is a description of findings in models, not of what happens in people.

**Research Note:** Portal to Wellness does not publish administration guidance. We do not provide dosing, routes, schedules, cycling or combination advice, and we cannot answer questions about use in humans or animals. Published trial and preclinical literature is where pharmacokinetic and administration data belongs; the compound pages below link the primary sources.

Bundle Pricing

## Save 20% when you buy these together.

Recovery & Repair Kit — all three compounds

BPC-157 + TB-500 — 10mg/vial (5mg each)
$55.20

IGF-1 LR3 — 1mg/vial
$49.60

KPV — 10mg/vial
$44.80

Bundle Total
$149.60

You save $37.40 vs. buying them separately ($187.00)

[Recovery & Repair Kit — all three compounds →](https://portaltowellness.net/shop/recovery-repair-bundle/)

Bundle pricing applied automatically at checkout. Each compound is also available individually.

All products on Portal to Wellness are sold for research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are a qualified researcher.

### Backed by the Research

Research on These Compounds [BPC-157: What the Preclinical Research Actually Shows](https://portaltowellness.net/research/bpc-157-preclinical-research/) [BPC-157 and TB-500: Preclinical Literature Compared](https://portaltowellness.net/research/the-recovery-stack-how-bpc-157-and-tb-500-work-together/) [TB-500 (Thymosin Beta-4): What the Research Explores](https://portaltowellness.net/research/tb-500-thymosin-beta-4-research/) [Recovery & Repair Research Compounds: A Complete Guide](https://portaltowellness.net/research/recovery-repair-research-compounds-guide/)

Shop the Compounds [BPC-157 + TB-500 Injectable](https://portaltowellness.net/shop/bpc-157-tb-500-injectable/) [IGF-1 LR3](https://portaltowellness.net/shop/igf-1-lr3/) [KPV](https://portaltowellness.net/shop/kpv/)

More Research [Browse the full PTW Research Hub →](https://portaltowellness.net/research/)

---

Source: https://portaltowellness.net/tissue-repair-kit/
Research use only. Terms: https://portaltowellness.net/research-use-only/